You have no choice in reading this article—maybe

Q: Moderna is rebranding its mRNA cancer vaccines as "individualized neoantigen therapy" to avoid vacci

Moderna is rebranding its mRNA cancer vaccines as "individualized neoantigen therapy" to avoid vaccine hesitancy despite the technology being a breakthrough cancer vaccine.

Q: Sam Altman's home was attacked twice in two days with gunfire and a Molotov cocktail by a suspect wh

Sam Altman's home was attacked twice in two days with gunfire and a Molotov cocktail by a suspect who wrote essays warning AI would end humanity.

Q: Wikipedia's vulnerable language versions are being corrupted by machine-translated articles, creatin

Wikipedia's vulnerable language versions are being corrupted by machine-translated articles, creating a doom spiral where AI systems like ChatGPT learn from junk data.

The Download from MIT Technology Review·Monday, April 13, 2026·5 min read

Technology AI/ML Science

Share𝕏 in

AI Summary

MIT Technology Review's newsletter covers neuroscientist Uri Maoz's research on free will and decision-making, Moderna's strategic rebranding of cancer vaccines as therapies to avoid vaccine hesitancy, and various AI developments including attacks on Sam Altman's home and military AI arms race.

Key Facts

✓Moderna is rebranding its mRNA cancer vaccines as "individualized neoantigen therapy" to avoid vaccine hesitancy despite the technology being a breakthrough cancer vaccine.

✓Sam Altman's home was attacked twice in two days with gunfire and a Molotov cocktail by a suspect who wrote essays warning AI would end humanity.

✓Wikipedia's vulnerable language versions are being corrupted by machine-translated articles, creating a doom spiral where AI systems like ChatGPT learn from junk data.

More from The Download from MIT Technology Review

A plan to make drugs in orbit is going commercial

MIT Technology Review's May 13, 2026 newsletter covers Varda Space Industries' commercial deal with United Therapeutics to manufacture drugs in microg

May 13

Three things in AI to watch, according to a Nobel-winning economist

MIT Technology Review's The Download covers Nobel-winning economist Daron Acemoglu's cautious but data-backed thesis on AI's limited productivity impa

May 12

What a Nobel-winning economist is watching in AI

Nobel Prize-winning economist Daron Acemoglu remains skeptical that AI agents will replace human workers at scale, arguing that jobs requiring multi-t

May 11